POST Online Media Lite Edition


Micreos appoints Matt Regan as CEO of its pharmaceutical business

Christian Fernsby |
The Hague, Netherlands - Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new pharmaceutical business that will be based in Switzerland.

Article continues below

Mr. Regan joins Micreos with extensive biopharmaceutical experience from almost 3 decades working with Global healthcare leaders including Abbott, Novo Nordisk, and AbbVie.


Koert Grasveld joined TerraPay as vice president, payments
TerraPay names Deepak Bhutra president of business development and strategy payments
Billups announces first European hire, Andrew Brunton
Carlos Tavares to leave Airbus board
Stellantis appoints Christine Feuell as Chrysler CEO